Revised SPC: Cablivi (caplacizumab) 10 mg powder and solvent for solution for injection

SPC updated to advise dosing of caplacizumab for thrombotic thrombocytopenic purpura in adolescents age ≥ 12 years and weighing ≥40 kg, is same as in adults (based on data pooled from clinical studies in adults to develop pharmacokinetic-pharmacodynamic population model).


electronic Medicines compendium